Company Search:
Advanced Search
Sponsored Links
Epigenomics AG Company Snapshot
Epigenomics AG operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Epigenomics AG with three other pharmaceutical manufacturers in Europe: Biocorp Sa of France (2015 sales of 2.46 million Euro [US$2.66 million] ), Premier Veterinary Group PLC of the United Kingdom (£2.25 million [US$2.81 million] of which 53% was Buying group), and Biotika a.s. which is based in Slovakia (1.89 million Slovak Koruny [US$2.05 million] of which 1,770% was Substances).

Sales Analysis. Epigenomics AG reported sales of 2.08 million Euro (US$2.25 million) for the year ending December of 2015. This represents an increase of 38.2% versus 2014, when the company's sales were 1.51 million Euro. Sales of Products Sales (Own and Third Party) saw an increase that was more than double the company's growth rate: sales were up 88.6% in 2015, from 830,000.00 Euro to 1.57 million Euro. Not all segments of Epigenomics AG experienced an increase in sales in 2015: sales of Research and Development fell 35.0% to 361,000.00 Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Epigenomics AG
  Stock Performance Chart for Epigenomics AG
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 5.33
(Figures in Euro)
1 Week 4.8%   13 Weeks 15.5%  
4 Weeks 21.1%   52 Weeks 3.4%  
Epigenomics AG Key Data:
  Ticker: ECX Country: Germany
  Exchanges: FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2015 Sales 2,082,000
(Year Ending Jan 2016).
Employees: 39
  Currency: Euro Market Cap: 109,499,568
  Fiscal Yr Ends: December Shares Outstanding: 20,544,009
  Share Type: STAMMAKTIE Closely Held Shares: 1,910,685
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.